On Friday, Shares of Starbucks Corporation (NASDAQ:SBUX), lost -0.75% to $54.28.
Starbucks Corporation, declared the company will present at the Goldman Sachs Global Retailing Conference on Thursday, September 10, 2015 at 3:10 p.m. ET.
Starbucks Corporation operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; Europe, Middle East, and Africa; China/Asia Pacific; and Channel Development.
Shares of Infoblox Inc (NYSE:BLOX), declined -8.00% to $18.28, during its last trading session.
Infoblox (BLOX), stated its financial results for its fourth fiscal quarter and fiscal year ended July 31, 2015. Total net revenue for the fourth quarter of fiscal 2015 was a record $87.0 million, an improvement of 34.0% on a year-over-year basis. Total net revenue for fiscal 2015 was a record $306.1 million, an improvement of 22.3% contrast with the total net revenue of $250.3 million in fiscal 2014.
On a GAAP basis, the Company stated a net loss of $4.7 million, or $0.08 net loss per fully diluted share, for the fourth quarter of fiscal 2015, contrast with a net loss of $9.5 million, or $0.17 net loss per fully diluted share, for the fourth quarter of fiscal 2014. For fiscal 2015, the Company stated a GAAP basis net loss of $27.1 million, or $0.48 net loss per fully diluted share, contrast with a net loss of $23.9 million, or $0.45 net loss per fully diluted share, in fiscal 2014.
The Company stated non-GAAP net income of $7.3 million, or $0.12 diluted net income per share on a non-GAAP weighted-average share basis, for the fourth quarter of fiscal 2015, contrast with non-GAAP net income of $1.9 million, or $0.03 diluted net income per share on a non-GAAP weighted-average share basis, for the fourth quarter of fiscal 2014. For fiscal 2015, on a non-GAAP basis, the Company stated net income of $22.7 million, or $0.38 diluted income per share contrast with net income of $19.5 million, or $0.34 diluted income per share, in fiscal 2014.
Infoblox Inc. develops, markets, and sells automated network control solutions worldwide. Its appliance-based solution combines real-time IP address administration with the automation of network control, and network change and configuration administration processes in physical and virtual appliances.
Finally, Bristol-Myers Squibb Co (NYSE:BMY), ended its last trade with -2.49% loss, and closed at $57.28.
Bristol-Myers Squibb Company, will host a teleconference on Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at the 16th Annual World Conference on Lung Cancer (WCLC) in Denver, CO. Company executives will provide an overview of data presented on our Immuno-Oncology portfolio at the meeting, and address inquiries from investors and analysts.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
